Agilent Technologies (A) Stock Forecast, Price & News

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 sell rating, 4 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" A shares.
View A analyst ratings or view top-rated stocks.

16 Wall Street research analysts have issued 1 year price objectives for Agilent Technologies' shares. Their A share price forecasts range from $110.00 to $170.00. On average, they predict the company's stock price to reach $146.72 in the next twelve months. This suggests a possible upside of 31.0% from the stock's current price.
View analysts price targets for A or view top-rated stocks among Wall Street analysts.

Agilent Technologies' stock was trading at $149.65 at the start of the year. Since then, A shares have decreased by 25.2% and is now trading at $112.01.
View the best growth stocks for 2023 here.

Agilent Technologies saw a increase in short interest in September. As of September 15th, there was short interest totaling 4,550,000 shares, an increase of 12.6% from the August 31st total of 4,040,000 shares. Based on an average daily trading volume, of 1,920,000 shares, the days-to-cover ratio is presently 2.4 days. Approximately 1.6% of the shares of the stock are short sold.
View Agilent Technologies' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 20th 2023.
View our A earnings forecast.

Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings results on Tuesday, August, 15th. The medical research company reported $1.43 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.07. The medical research company earned $1.67 billion during the quarter, compared to analyst estimates of $1.66 billion. Agilent Technologies had a trailing twelve-month return on equity of 29.86% and a net margin of 16.20%. The firm's quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.34 earnings per share.
Read the conference call transcript.

Agilent Technologies announced a quarterly dividend on Wednesday, September 20th. Shareholders of record on Tuesday, October 3rd will be given a dividend of $0.225 per share on Wednesday, October 25th. This represents a $0.90 annualized dividend and a dividend yield of 0.80%. The ex-dividend date of this dividend is Monday, October 2nd.
Read our dividend analysis for A.

ETFs with the largest weight of Agilent Technologies (NYSE:A) stock in their portfolio include Global X Genomics & Biotechnology ETF (GNOM), Global X Telemedicine & Digital Health ETF (EDOC), ProShares Nanotechnology ETF (TINY), First Trust Water ETF (FIW), Engine No. 1 Transform Supply Chain ETF (SUPP), Kelly CRISPR & Gene Editing Technology ETF (XDNA), WisdomTree U.S. AI Enhanced Value Fund (AIVL) and Invesco Focused Discovery Growth ETF (IVDG).

Agilent Technologies (NYSE:A) pays an annual dividend of $0.90 per share and currently has a dividend yield of 0.81%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 23.56%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 15.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

Agilent Technologies announced that its board has initiated a stock repurchase program on Monday, January 9th 2023, which authorizes the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 4.4% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board of directors believes its shares are undervalued.

Agilent Technologies issued an update on its fourth quarter 2023 earnings guidance on Tuesday, August, 22nd. The company provided earnings per share guidance of $1.33-$1.36 for the period, compared to the consensus estimate of $1.35. The company issued revenue guidance of $1.66 billion-$1.71 billion, compared to the consensus revenue estimate of $1.69 billion.

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of A stock can currently be purchased for approximately $112.01.

Agilent Technologies (NYSE:A) has a market capitalization of $32.77 billion and generates $6.85 billion in revenue each year. The medical research company earns $1.25 billion in net income (profit) each year or $3.82 on an earnings per share basis.

The company employs 18,100 workers across the globe.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The official website for the company is www.agilent.com. The medical research company can be reached via phone at (800) 227-9770, via email at investor_relations@agilent.com, or via fax at 408-345-8474.